Pfizer's Multicultural Health Equity Collective Marks 10 Years of Progress

A decade ago, despite many existing partnerships with multicultural groups, Pfizer recognized a need to address persistent health inequities more holistically and work alongside organizations and leaders to truly understand and help address the unique and evolving needs of marginalized communities.

Advocacy, Strength, and Hope in the Face of Metastatic Melanoma: Bruce and Chris's Story

In 2013, Bruce's life changed. He was living in sunny Florida with Chris, his wife of over 20 years, when he received an unexpected diagnosis: metastatic melanoma-the most aggressive form of skin cancer.

Why Immunising Mothers Could Help Protect Newborns

Up to 1 in 4 pregnant individuals carry group Bstrep bacteria in their body and may pass it to their baby. In a new Healthier Together video, we explore the potential of Maternal Immunization in preventing GBS infections.

Pfizer Goes Live in SXSW's Podcast Lounge

For more than a quarter of a century, SXSW has been a must-do event on the calendars of consumers, celebrities, and cognoscenti. Over the years, our leadership has showcased the latest scientific breakthroughs and shared our unique perspectives on the present - and future - of healthcare to the event's thousands of attendees.

TIME Names Pfizer as One of the Most Influential Companies

Pfizer is proud to be recognized by TIME magazine as one of the influential companies of 2024.

Connected. Active. Involved.

Welcome to the official website for retirees of Pfizer and its legacy organizations.

Pfizer News

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
June 03, 2024
Pfizer's ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
June 01, 2024
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
June 01, 2024
Pfizer's LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
May 31, 2024
Pfizer Announces New Chief Strategy and Innovation Officer
May 06, 2024
Pfizer Reports First-Quarter 2024 Results
May 01, 2024
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
April 29, 2024
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
April 29, 2024
U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
April 26, 2024
Pfizer Announces 2024 Shareholder Meeting Preliminary Results
April 25, 2024
European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
April 22, 2024
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
April 11, 2024
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
April 09, 2024
Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts
March 20, 2024
European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
March 13, 2024
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
March 12, 2024
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
March 5, 2024
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
February 29, 2024
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
February 29, 2024
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 26, 2024

Join the Pfizer Plus Community Corner

When you join the community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • Community